SEC Form DEFA14A filed by TScan Therapeutics Inc.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a)
of the Securities Exchange Act of 1934 (Amendment No. )
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
| ☐ | Preliminary Proxy Statement |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☐ | Definitive Proxy Statement |
| ☒ | Definitive Additional Materials |
| ☐ | Soliciting Material Pursuant to §240.14a-12 |
TSCAN THERAPEUTICS, INC.
(Name of Registrant as Specified in its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
| ☒ | No fee required. |
| ☐ | Fee paid previously with preliminary materials. |
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
Your Vote Counts!TSCAN THERAPEUTICS, INC. 2025 Annual MeetingVote by June 29, 202511:59 PM ETTHERAPEUTICSTSCAN THERAPEUTICS, INC.830 WINTER STREETYou invested in TSCAN THERAPEUTICS, INC. and it’s time to vote!You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy material for the stockholder meeting to be held on June 30, 2025.Get informed before you voteView the Annual Report, and Proxy Statement online OR you can receive a free paper or email copy of the material(s) by requesting prior to June 16, 2025. If you would like to request a copy of the material(s) for this and/or future stockholder meetings, you may (1) visitwww.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to [email protected]. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.Smartphone users Vote Virtually at the Meeting1Point your camera here and June 30, 2025 8:30 AM EDTvote without entering a Control numberMeeting to be held via internetwww.virtualshareholdermeeting.com/TCRX2025 check the meeting materials for any special requirements for meeting attendance.
Vote at www.ProxyVote.com THIS IS NOT A VOTABLE BALLOTThis is an overview of the proposals being presented at the upcoming stockholder meeting. Please follow the instructions on the reverse side to vote these important matters.BoardVoting Items Recommends1. To elect three Class I directors to the Company’s Board of DirectorsNominees: For01 Stephen Biggar 02 Gavin MacBeath 03 Garry Nicholson2 To ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm For for the fiscal year ending December 31, 2025NOTE: The proxies are authorized to vote, in their discretion, upon such other business as may properly come before the meeting or any adjournment thereof.